Lv13
48 积分 2023-09-22 加入
Pharmacological targeting of netrin-1 inhibits EMT in cancer
16小时前
待确认
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies
2天前
已完结
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance
7天前
已完结
A coiled-coil masking domain for selective activation of therapeutic antibodies
1个月前
已完结
A novel anti-HER2/EGFR bispecific antibody–drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs
2个月前
已完结
Trastuzumab Deruxtecan (T-DXd) Resistance via Loss of HER2 Expression and Binding
3个月前
已完结
Tumor Microenvironment-Responsive Antibody Fragment-Cleavable PEGylated Drug Conjugates (AFCDC) for Improved Tumor Penetration and Antitumor Efficacy
3个月前
已完结
Dual-Targeting Multivalent Aptamer-Drug Hybrids for Synergistic Cancer Immunotherapy
4个月前
已完结
Abstract 1523: Subcutaneous dosing of amatoxin-based ADCs increases the therapeutic index
5个月前
已完结
Precision Cuproptosis Activation via HER2‐Targeted Bimetallic MOF Nanoreactors Breaks Metabolic Adaptation in Aggressive Breast Cancers
5个月前
已完结
皖公网安备34019202002308
